Bank of Montreal’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,559
Closed -$1.33M 4260
2024
Q2
$1.33M Buy
+15,559
New +$1.06M ﹤0.01% 1875
2023
Q3
Sell
-12,292
Closed -$1.23M 4256
2023
Q2
$1.23M Buy
+12,292
New +$1.16M ﹤0.01% 2066
2021
Q2
Sell
-95
Closed -$8K 4903
2021
Q1
$8K Sell
95
-432
-82% -$38K ﹤0.01% 4473
2020
Q4
$46K Buy
527
+369
+234% +$31.5K ﹤0.01% 3993
2020
Q3
$13K Sell
158
-113
-42% -$9.38K ﹤0.01% 4038
2020
Q2
$22K Buy
+271
New +$24.3K ﹤0.01% 3817
2020
Q1
Sell
-441
Closed -$48K 4736
2019
Q4
$48K Buy
441
+136
+45% +$13.8K ﹤0.01% 3860
2019
Q3
$29K Sell
305
-83
-21% -$7.71K ﹤0.01% 3885
2019
Q2
$37K Buy
388
+294
+313% +$24.8K ﹤0.01% 3832
2019
Q1
$8K Sell
94
-48
-34% -$4.22K ﹤0.01% 3943
2018
Q4
$12K Buy
142
+24
+20% +$2.11K ﹤0.01% 3839
2018
Q3
$11K Hold
118
﹤0.01% 3906
2018
Q2
$13K Buy
118
+24
+26% +$2.51K ﹤0.01% 3888
2018
Q1
$9K Hold
94
﹤0.01% 3792
2017
Q4
$8K Buy
+94
New +$7.34K ﹤0.01% 3851
2014
Q3
Sell
-80
Closed -$4K 4415
2014
Q2
$4K Sell
80
-331
-81% -$17K ﹤0.01% 4286
2014
Q1
$24K Sell
411
-333
-45% -$18.2K ﹤0.01% 3424
2013
Q4
$43K Hold
744
﹤0.01% 2934
2013
Q3
$44K Hold
744
﹤0.01% 2886
2013
Q2
$40K Buy
+744
New +$35K ﹤0.01% 2805

Other funds holding UTMD

Bank of Montreal's UTMD Position: Q3 2024 in Review

Bank of Montreal sold out of Utah Medical Products (UTMD) in Q3 2024, closing a stake of 15,559 shares — an estimated $1.33M sold.

Bank of Montreal first reported a position in UTMD in Q2 2013 and held it in 20 quarters. The position peaked at $1.33M in Q2 2024. 110 funds tracked by Wall St. Rank hold UTMD as of Q3 2024.

  • Bank of Montreal reported no remaining Utah Medical Products position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 15,559 Utah Medical Products shares in Q3 2024, an estimated $1.33M.
  • Bank of Montreal first reported a position in Utah Medical Products in Q2 2013 and held it in 20 quarters.
  • Bank of Montreal's Utah Medical Products position peaked at $1.33M in Q2 2024.
  • 110 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.